PROF Profound Medical Corp.
$5.65▲ +1.71%
Healthcare
Other
Volume 75.8K
Avg Volume (10D) 187.7K
Key Metrics & Fundamentals
Market Cap
$206.27M
P/E Ratio
–
Div Yield
0.00%
52W Range
4.80 - 8.95
% vs 50 MA
-10.05%
% vs 200 MA
-15.82%
RSI-14
41.4
MACD Histogram
-0.0800
Beta (1Y vs SPY)
1.61
Free Cash Flow
-$11.34M
Gross Rev
$2.48M
Gross Profit
$1.95M
EBITDA
-$12.18M
COGS
$536,000
Operating Exp
$13.01M
Operating Income
-$11.07M
EBIT
-$11.07M
Pretax Income
-$9.49M
Net Income
-$9.54M
EPS (Diluted)
-0.26
Price & Volume History
Loading chart…
Recent News
3 Canadian AI Healthcare Stocks With Up To 8.7x P S
Simply Wall St. · Oct 25, 2026 1:08 PM ET
Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let’s Huddle’ Webinar
GlobeNewswire · Oct 22, 2026 4:15 PM ET
3 Canadian AI Healthcare Stocks With Market Caps Up To CA$312 Million
Simply Wall St. · Oct 18, 2026 12:11 PM ET
Does Profound Medical (PROF) Have the Potential to Rally 58.77% as Wall Street Analysts Expect?
Zacks · Oct 14, 2026 8:55 AM ET
TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion Opportunity
GlobeNewswire · Oct 14, 2026 7:30 AM ET
Profound Medical And 2 Canadian AI Healthcare Stocks To Watch
Simply Wall St. · Oct 11, 2026 11:10 AM ET
Profound Medical and Telix Pharmaceuticals Partner to Advance Prostate Cancer Imaging and Treatment Education
InvestorsHub · Oct 9, 2026 8:38 AM ET
Profound Medical, Telix Pharmaceuticals Enter Prostate-Care Education Agreement
MT Newswires · Oct 9, 2026 8:35 AM ET
Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
GlobeNewswire · Oct 9, 2026 7:45 AM ET
Strength Seen in Profound Medical (PROF): Can Its 21.7% Jump Turn into More Strength?
Zacks · Oct 9, 2026 6:42 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See PROF's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.